Infectious Disease Therapeutics Market Report: Global Industry Overview and InsightsPosted by Roger on January 18th, 2024 Infectious disease therapeutics help treat a wide range of viral, bacterial, fungal and parasitic infections by targeting their causative pathogens. Antiviral drugs play a vital role in controlling the spread of infectious illnesses like influenza, hepatitis and HIV/AIDS. They act by inhibiting the replication of viruses inside human cells or enhancing the immune system’s ability to fight infections. The growing prevalence of antimicrobial resistance and emergence of new pathogens have increased the need for more effective antiviral therapies. The increasing demand for antiviral drugs to treat infectious diseases like HIV, hepatitis and influenza is one of the major trends fueling the infectious disease therapeutics market growth. According to medical experts, antiviral drugs can help reduce illness severity, limit virus spread and prevent potential outbreaks. Recent clinical trials have demonstrated that some antiviral medications if used properly, can significantly reduce the risk of hospitalization from viral infections like RSV and influenza. This has prompted many governments and healthcare organizations to stockpile important antiviral drugs. Furthermore, ongoing research for improved antiviral formulations with fewer side effects and higher efficacy is also boosting the market development.
The global infectious disease therapeutics market is dominated by the anti-infective sub segment. Anti-infective drugs are used to treat or prevent infectious diseases caused by microorganisms such as bacteria, viruses, parasites or fungi. They work by either killing the pathogens or preventing them from multiplying and spreading in the body. Anti-infective drugs account for over 50% of the market share as they are widely used to treat a variety of infections affecting different parts and systems of the body. The global infectious disease therapeutics market is expected to witness high growth during the forecast period of 2023 to 2030. The global Infectious Disease Therapeutics Market is estimated to be valued at US$ 170.67 Bn in 2023 and is expected to exhibit a CAGR of 3.7% over the forecast period 2023 to 2030.
Like it? Share it!More by this author |